Comprehensive Analysis of Phagocytosis-Related Regulators to Aid Prognostic Prediction and Immunotherapy in Patients with Low-Grade Glioma

Figure 13

The assessment of immunotherapy. (a and b) Difference of risk score in different treatment response groups. (c) Kaplan-Meier survival analysis of anti-PD-L1 cohort (IMvigor210). (d) ROC analysis of different risk signatures in TCGA-TC cohort.

(a)

(b)

(c)

(d)